RxDoctor Payments Data

Samaaneh Moezzi

Physician Assistant · Germantown, MDNPI 1093328387

Payments from drug & device makers

$1,479in general payments, 2019–2025

Across 56 payments — averaging $26.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$355
  • AbbVie$341
  • Takeda Pharmaceuticals U.S.A., Inc.$268
  • Supernus Pharmaceuticals, Inc.$172
  • Sunovion Pharmaceuticals Inc.$136
  • Otsuka America Pharmaceutical, Inc.$71
  • plus $135 from 4 others

What the payments were for

  • Food & beverage$1,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,479 in reported general payments places this provider in the 80th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$7,988
Medicare patients
18
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate40$3,063
Lisdexamfetamine Dimesylate12$2,286
Venlafaxine Hcl ErVenlafaxine Hcl24$1,169
Methylphenidate Hcl35$1,144
Olanzapine13$974
Gabapentin36$686
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine30$681
Bupropion XlBupropion Hcl21$680
Duloxetine Hcl25$671
Ziprasidone Hcl13$618
Aripiprazole28$580
Mirtazapine14$505
Trazodone Hcl12$417
Lorazepam41$396
Prazosin Hcl22$370

Paid to pharmacies, not to this prescriber.

Other physician assistant in Germantown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →